Fountain Life, a Florida-based longevity company co-founded by Tony Robbins, Dr. Peter Diamandis, and CEO Dr. William Kapp, has raised $18 million in a Series B round led by EOS Ventures.
Existing board members, including Dr. Bob Hariri, Ashley Furniture CEO Todd Wanek, and Indian business leader B.K. Modi, also participated.
Founded in 2020 from the merger of Kapp’s Longevity Performance Center and Robbins and Diamandis’s Fountain Therapeutics, Fountain Life operates premium health centers focused on early detection, optimization, and regenerative therapies.
Advertisement
High-tech prevention for the ultra-health-conscious
The company uses advanced blood tests and full-body scans to track over 100 biomarkers, aiming to catch illnesses in their earliest, often asymptomatic stages. Patients can monitor results via Zori, an AI-powered app, and receive personalized treatment plans.
The company’s memberships cost $21,500/year for comprehensive testing and physician access, or $10,000/year for testing and AI insights only. Kapp cites multiple cases where screenings have detected life-threatening conditions, including early-stage kidney cancer and brain aneurysms. Hot Design feature is patent-pending and designed to align with strict enterprise security protocols.
Expansion plans
With current locations in Naples, Orlando, Dallas, and Westchester (NY), Fountain Life will open a Houston center in December 2025, followed by Los Angeles and Miami in 2026. The new funding will also support a clinic development program to train other medical facilities in its methods, aiming to lower costs and broaden access.
